You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sAML

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Aachen, NRW, Germany
  • +2 more
Mar 29, 2023

Secondary Acute Myeloid Leukemia Trial in Nanjing (Venetoclax;Azacitidine;Homoharringtonine)

Recruiting
  • Secondary Acute Myeloid Leukemia
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Aug 21, 2022

MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • unrelated umbilical cord blood
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Oct 16, 2022

Secondary Acute Myeloid Leukemia Evolving From MDS, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in

Recruiting
  • Secondary Acute Myeloid Leukemia Evolving From MDS
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +4 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 5, 2022

Leukemia, Myeloid, Acute Trial in Jerusalem (Vyxeos, Mylotarg)

Recruiting
  • Leukemia, Myeloid, Acute
  • Jerusalem, Yerushalayim, Israel
    Shaare Zedek Medical Center
Oct 25, 2022

Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Duesseldorf (Lenalidomide, Azacitidine, Donor

Completed
  • Leukemia, Myeloid, Acute
  • +2 more
  • Duesseldorf, NRW, Germany
    University Hospital Duesseldorf, Dept. of Hematology, Oncology a
May 26, 2020

Myeloproliferative Tumors Trial in Taoyuan

Enrolling by invitation
  • Myeloproliferative Neoplasms
    • Taoyuan, State, Taiwan
      Chang Gung Memorial Hospital-Linkou
    Aug 4, 2021

    Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))

    Not yet recruiting
    • Polycythemia Vera
    • Ropeginterferon alfa-2b-njft (P1101)
    • (no location specified)
    Jul 28, 2022

    Essential Thrombocythemia Trial (Ropeginterferon alfa-2b-njft (P1101))

    Not yet recruiting
    • Essential Thrombocythemia
    • Ropeginterferon alfa-2b-njft (P1101)
    • (no location specified)
    Jul 28, 2022

    MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,

    Recruiting
    • Myelodysplastic Syndromes
    • Secondary Acute Myeloid Leukemia
    • CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
    • Standard of Care Chemotherapy
    • Tampa, Florida
      Moffitt Cancer Center
    Sep 27, 2022

    Biospecimen Acquisition for Myelodysplastic Syndromes

    Recruiting
    • Myelodysplastic Syndromes
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 20, 2022

      MDS Trial in Innsbruck (Next Generation Sequencing, Tumorimmunological examinations - multiplex assays/quantitative polymerase

      Recruiting
      • Myelodysplastic Syndromes
      • Next Generation Sequencing
      • +5 more
      • Innsbruck, Tyrol, Austria
        Medical University of Innsbruck
      Apr 6, 2022

      MDS, Secondary Acute Myeloid Leukemia (AML) Trial in United States (Clofarabine)

      Completed
      Has Results
      • Myelodysplastic Syndromes
      • Secondary Acute Myeloid Leukemia (AML)
      • Chicago, Illinois
      • +5 more
      Mar 15, 2022

      Myelodysplastic Syndrome Trial in Worldwide (eltrombopag olamine, Placebo)

      Completed
      • Myelodysplastic Syndrome
      • eltrombopag olamine
      • Placebo
      • Birmingham, Alabama
      • +64 more
      Nov 8, 2017

      Acute Leukaemia Trial in Worldwide (Daunorubicin, Cytarabine, Eltrombopag)

      Completed
      Has Results
      • Acute Leukaemia
      • Farmington, Connecticut
      • +41 more
      Aug 27, 2019

      MDS, Secondary Acute Myeloid Leukemia Trial in Worldwide (Reduced Intensity Conditioning, Myeloablative conditioning)

      Terminated
      • Myelodysplastic Syndromes
      • Secondary Acute Myeloid Leukemia
      • Reduced Intensity Conditioning
      • Myeloablative conditioning
      • Düsseldorf, Germany
      • +13 more
      Apr 2, 2015

      Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Tel-Hashomer (treosulfan, Treosulfan)

      Completed
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
      • Tel-Hashomer, Israel
        Chaim Sheba Medical Center
      Nov 30, 2015

      Acute Myeloid Leukemia Trial in Georgia, Ukraine (Amonafide + cytarabine)

      Unknown status
      • Acute Myeloid Leukemia
      • Amonafide + cytarabine
      • Tbilisi, Georgia
      • +5 more
      Jan 14, 2011

      Leukemia, MDS Trial in Worldwide (cytarabine, etoposide, idarubicin)

      Unknown status
      • Leukemia
      • Myelodysplastic Syndromes
      • Antwerp, Belgium
      • +39 more
      May 26, 2010

      Secondary Acute Myeloid Leukemia (Secondary AML, sAML) Trial in Worldwide (Daunorubicin and Cytarabine, Amonafide and

      Unknown status
      • Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
      • Daunorubicin and Cytarabine
      • Amonafide and Cytarabine
      • Los Angelas, California
      • +157 more
      Oct 12, 2010